Respiratory failure & ventilation

Inhaled nitric oxide for acute respiratory distress syndrome in adults: a systematic review and meta-analysis

J Intensive CarePublished Systematic review and meta-analysis of randomised trials

Pooled result · Low certaintyResult — go to the resultRelative risk 1.07 95% CI 0.93–1.23

Authors' conclusion

Although iNO may improve oxygenation slightly, it may not confer survival or other patient-centered benefits and may increase the need for RRT.

Study context

Population
Adults with acute respiratory distress syndrome (ARDS)
Participants
1,302 adults · 11 RCTs
Comparison
Inhaled nitric oxide (iNO) added to standard care vs standard care
Outcome
Mortality at the longest follow-up
Follow-up
Longest
Methodological detailsrandom-effects model, Cochrane RoB 2, GRADE
  • Random-effects model
  • Cochrane RoB 2
  • GRADE

Pooled result

Low certainty

Relative risk

1.07

95% CI 0.93–1.23

iNO vs Standard care
RR 1.07 (95% CI 0.93–1.23)

As reported in the abstract

Further pooled results

OutcomeMean difference (mmHg) (95% CI)
PaO2/FiO2 ratioI2 = 0%; low certainty15.03 (6.19–23.86)
OutcomeRR (95% CI)
ECMO useI2 = 45%; very low certainty0.45 (0.10–2.17)

Other secondary outcomes

No clear differences observed

Reintubation

No study reported data

Safety

OutcomeRR (95% CI)
Need for RRTI2 = 0%; low certainty1.56 (1.17–2.08)

Original publication

Inhaled nitric oxide for acute respiratory distress syndrome in adults: a systematic review and meta-analysis. J Intensive Care. Published 2 January 2026. doi:10.1186/s40560-025-00845-4

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.